Alam, U., Rath, S., Ansab, M., Lal, A. (2026). High-dose furmonertinib in
                    <i>EGFR</i>
                    -mutant NSCLC with brain metastases after EGFR-TKI resistance.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e14028